[Mechanical complications of myocardial infarction in elderly patients]

A Marui1, M Komeda

  • 1Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Insights

Therapeutic strategies for elderly patients with mechanical complications after myocardial infarction, including postinfarction ventricular septal perforation (PVSP), ischemic cardiomyopathy (ICM), and ischemic mitral regurgitation (IMR), are discussed. Prompt intervention and LV-restoration surgery are key, but novel treatments are needed for high-risk cases.

Area of Science:

  • Cardiovascular Surgery
  • Geriatric Cardiology
  • Myocardial Infarction Complications

Context:

  • Mechanical complications post-myocardial infarction (MI) pose significant risks in elderly patients.
  • Postinfarction ventricular septal perforation (PVSP), ischemic cardiomyopathy (ICM), and ischemic mitral regurgitation (IMR) are critical conditions requiring specialized management.
  • Left ventricular (LV) geometry and mitral valve (MV) function are intricately linked in ischemic heart disease.

Purpose:

  • To outline therapeutic strategies for managing mechanical complications of MI in the elderly.
  • To emphasize the importance of hemodynamic support and timely surgical intervention for PVSP.
  • To highlight the necessity of comprehensive LV and MV geometrical repair for ICM and IMR.

Summary:

  • For PVSP in the elderly, maintaining hemodynamics with cardiac support devices and prompt surgery (e.g., infarct exclusion) before cardiogenic shock is crucial.
  • For ICM and IMR, total MV-LV geometrical repair involving LV restoration surgery, MV repair, and coronary revascularization is essential.
  • Surgical techniques like the septal anterior ventricular exclusion (SAVE) and apex-sparing Batista operation, along with mitral annuluoplasty, aim to maximize LV function and sphericity.

Impact:

  • Improved operative outcomes for PVSP through early intervention and hemodynamic support.
  • Enhanced LV function and morphological correction in ICM and IMR patients via integrated surgical approaches.
  • Identifies the ongoing challenges in managing elderly patients with severely compromised cardiac function and underscores the need for advanced therapies like regenerative medicine.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...